Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas

Pancreatic cancer is still a disease of high mortality despite availability of diagnostic techniques. Mucins (MUC) play crucial roles in carcinogenesis and tumor invasion in pancreatic neoplasms. MUC1 and MUC4 are high molecular weight transmembrane mucins. These are overexpressed in many carcinomas...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Yokoyama, Seiya, Higashi, Michiyo, Kitamoto, Sho, Oeldorf, Monika, Knippschild, Uwe, Kornmann, Marko, Maemura, Kosei, Kurahara, Hiroshi, Wiest, Edwin, Hamada, Tomofumi, Kitazono, Ikumi, Goto, Yuko, Tasaki, Takashi, Hiraki, Tsubasa, Hatanaka, Kazuhito, Mataki, Yuko, Taguchi, Hiroki, Hashimoto, Shinichi, Batra, Surinder K., Tanimoto, Akihide, Yonezawa, Suguru, Hollingsworth, Michael A.
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2016
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173155/
https://ncbi.nlm.nih.gov/pubmed/27283771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9924
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים